Table 3.
Pre-treatment predictors of response in the remission and non-remission groups at 14 weeks
| Remission group (n=11) |
Non-remission group (n=15) |
P-value | |
| Age, median (range), y | 50 (21–73) | 45 (19–77) | 0.460 |
| Sex (male/female) | 8/3 | 11/4 | 0.566 |
| Disease duration of UC, median (range), y | 9.6 (2.3–31.0) | 4.0 (0.5–41.6) | 0.197 |
| Pancolitis (n, %) | 8 (73) | 11 (73) | 0.566 |
| Steroid resistance (n, %) | 5 (45) | 6 (40) | 0.545 |
| Prior use of TNFα antagonists: none (n, %) | 5 (45) | 8 (53) | 0.534 |
| 1 agent (n, %) | 4 (36) | 6 (40) | 0.553 |
| 2 agents (n, %) | 2 (18) | 1 (7) | 0.519 |
| WBC, median (range), /μL | 7600 (7000–19500) |
6200 (3300–12200) |
0.124 |
| Hb, median (range), g/dL | 14.0 (9–17.4) | 11.0 (8.7–14.5) | 0.029 |
| Alb, median (range), g/dL | 4.0 (2.9–4.4) | 3.5 (2.1–4.6) | 0.158 |
| Plt, median (range), 103/μL | 296 (223–549) | 280 (122–465) | 0.323 |
| CRP, median (range), mg/dL | 0.16 (0.02–5.41) | 0.43 (0–7.98) | 0.475 |
| ESR per hour, median (range), mm | 10.0 (2–60) | 26.0 (4–70) | 0.323 |
| CAI score, median (range) | 6 (4–11) | 8 (4–14) | 0.509 |
| UCEIS, median (range) | 4 (4–7) | 4 (3–6) | 0.545 |
UC: ulcerative colitis
TNFα: tumor necrosis factors alpha
WBC: white blood cell
Hb: hemoglobin
Alb: albumin
Plt: platelet
CRP: C-reactive protein
ESR: erythrocyte sedimentation rate
CAI: Clinical Activity Index
UCEIS: Ulcerative Colitis Endoscopic Index of Severity